Send us Feedback

Inspire Pharmaceuticals (ISPH)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

ISPH » Topics » OPTION GRANTS IN 2004

This excerpt taken from the ISPH DEF 14A filed Apr 26, 2005.

OPTION GRANTS IN 2004

 

The following stock option grants were made to the named executive officers during the fiscal year ended December 31, 2004.

 

Name

    Number of
Securities
Underlying
Options
Granted
    

% of Total
Options Granted
to Employees

In Fiscal Year

    

Exercise or
Base Price

($/Share)

    Expiration
Date
   

Potential Realizable

Value of Assumed

Annual Rates of Stock

Price Appreciation for

Option Term(1)

             5%
    10%

Christy L. Shaffer

    35,000 (2)   3.3 %   $ 12.80    3/15/14    $ 281,745    $ 713,997
     35,000 (3)   3.3 %   $ 15.65    9/28/14    $ 344,477    $ 872,972

Donald J. Kellerman

    9,500 (2)   0.9 %   $ 12.80    3/15/14    $ 76,474    $ 193,799
     9,800 (3)   0.9 %   $ 15.65    9/28/14    $ 96,454    $ 244,432

Gregory J. Mossinghoff

    —     —       —    —      —      —

Joseph K. Schachle

    10,000 (2)   0.9 %   $ 12.80    3/15/14    $ 80,499    $ 203,999
     10,000 (3)   0.9 %   $ 15.65    9/28/14    $ 98,422    $ 249,421

Benjamin R. Yerxa

    9,500 (2)   0.9 %   $ 12.80    3/15/14    $ 76,474    $ 193,799
     9,700 (3)   0.9 %   $ 15.65    9/28/14    $ 95,469    $ 241,938
(1)   The potential realizable value is calculated based on the fair market value of our common stock on the date of the grant. These amounts only represent certain assumed rates of appreciation established by the Securities and Exchange Commission. There can be no assurance that the amounts reflected in this table or the associated rates of appreciation will be achieved.
(2)   These options were granted pursuant to our Amended and Restated 1995 Stock Plan, as amended. The shares underlying the options are exercisable at an exercise price equal to the fair market value on the date of the grant. Each option is exercisable as to one-quarter (1/4) of the shares underlying the option at any time after March 15, 2005 and as to one-forty-eighth (1/48) of the shares each month for 36 months thereafter.
(3)   This option was granted pursuant to our Amended and Restated 1995 Stock Plan, as amended. The shares underlying the option are exercisable at an exercise price equal to the fair market value on the date of the grant. Each option is exercisable as to one-quarter (1/4) of the shares underlying the option at any time after September 28, 2005 and as to one-forty-eighth (1/48) of the shares each month for 36 months thereafter.

 

25

"OPTION GRANTS IN 2004" elsewhere:

Adolor (ADLR)
ISTA Pharmaceuticals (ISTA)
Medicines Company (MDCO)
Pain Therapeutics (PTIE)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki